2025Zolbetuximab (Zolbetuximab)-Vyloy How much does it cost to buy it?

Zolbetuximab-Vyloy (Zolbetuximab-Vyloy) is not yet fully available globally, and specific purchase channels depend on the approval progress of the drug in different countries and regions. As a monoclonal antibody targeting Claudin 18.2 (CLDN18.2), it is mainly used to treat patients with advanced gastric cancer and gastroesophageal junction adenocarcinoma (GEJ adenocarcinoma). Currently, zotuximab is developed by Astellas Pharma of Japan and has completed pivotal Phase III clinical trials (SPOTLIGHT and GLOW studies). Research data shows that it performs well in improving progression-free survival (PFS) and overall survival (OS).

Zotuximab is a fully human monoclonal antibody. Its main mechanism is to inhibit the proliferation and spread of tumor cells by targeting specific antigens on the surface of tumor cells. This drug is available as an injection and is usually given intravenously. Injectable preparations are characterized by their efficient drug delivery system, which can quickly enter the patient's blood circulation and ensure that the drug takes effect quickly in the body.

The domestic original drug of zotuximab is already on the market, but due to its short time on the market, the specific price has not yet been determined, and it has not yet been included in medical insurance. Therefore, patients should consult relevant medical institutions or pharmacies for the latest information when purchasing. The original version of this drug is available overseas in Europe and Japan. The common specification is 100mg. Each box may be sold for more than 7,000 yuan (the price will change due to exchange rate fluctuations). There are currently no generic versions of zotuximab on the market. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.

Reference: https://medlineplus.gov/druginfo/meds/a624072.html